Evaluation the preventive effects of purgative manna on neonate’s icter in Sanandaj, Iran

The requested reference [ccf04e2c3ae4075c5e211982218f8e7e48414788] no longer exists in our database. It has been replaced by the current reference: [1ab91e828b29dd031ca74299f2aafb7584bdef63]

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2010
INTERVENTION: Control: Placebo drop produced by Sobhan Co. oral 5 drop/TDS Intervention 1: Intervention: Bilinaster drop produced by Sobhan Co. oral 5 drop/TDS (Twenty four hours after birth, for three days). Intervention 2: Control: Placebo drop produced by Sobhan Co. oral 5 drop/TDS. Intervention: Bilinaster drop produced by Sobhan Co. oral 5 drop/TDS (Twenty four hours after birth, for three days) Treatment ‐ Drugs CONDITION: neonatal icterus. ; Neonatal jaundice from other and unspecified causes Neonatal jaundice from other and unspecified causes PRIMARY OUTCOME: Icterus. Timepoint: Day 3‐5. Method of measurement: clinical examination and Lab exam. INCLUSION CRITERIA: INCLUSION CRITERIA: Full term neonate. Exclusion criteria: Congenital anomalies, Icter in day 1
Epistemonikos ID: 36a107955e63518d448958eb67bd23e9f27ce5eb
First added on: Aug 22, 2024